Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +34.35%
#2 Siren Siren +31.73%
#3 OriginTrail OriginTrail +18.20%
#4 Purr Purr +17.28%
#5 龙虾 (Lobster) 龙虾 (Lobster) +12.28%
#6 Ethena Staked ENA Ethena Staked ENA +11.62%
#7 Wrapped XPL Wrapped XPL +11.23%
#8 DigiByte DigiByte +11.00%
#9 Collect on Fanable Collect on Fanable +10.98%
#10 Plasma Plasma +10.85%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Clasificación en acciones #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Precio por acción
$50.82
Última sincronización: 2026-08-11
Capitalización bursátil
$102.09M
Cambio (1 día)
1.90%
Cambio (1 año)
-
País
US
Comercio Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Categoría

Healthcare
Precio COAG con Capital del mercado a B
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
COAG
$50.82
Capitalización de mercado de Hemab Therapeutics Holdings, Inc. Common Stock(COAG)
Capitalización bursátil: $102.09M
A fecha de August 2026, Hemab Therapeutics Holdings, Inc. Common Stock tiene una capitalización de mercado de $102.09M. Esto convierte a Hemab Therapeutics Holdings, Inc. Common Stock en la 21709th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Hemab Therapeutics Holdings, Inc. Common Stock desde 2026 hasta 2026
COAG en comparación con los más populares 5 títulos stocks
Precio por COAG Activo B Capital del mercado en B Resultados
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,594,322 $102.09M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +5,104,822.70%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,263,459 $102.09M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,453,775.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,072,162 $102.09M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +4,077,354.21%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,788,562 $102.09M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,519,305.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,390,338 $102.09M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,735,708.14%